Anna Åstrand

Publications

2026

Anna Åstrand, Emiliano Laudadio, Prince S. Gameli, Laura Martin, Jeremy Carlier, Francesco P. Busardo, Johan Dahlén, Xiongyu Wu, Peter Konradsson, Svante Vikingsson, Robert Kronstrand, Henrik Green (2026) Structure-activity relationship of prevalent synthetic cannabinoid metabolites on hCB1 in vitro and in silico dynamics Acta Pharmacologica Sinica, Vol. 47, p. 776-789 (Article in journal) https://dx.doi.org/10.1038/s41401-025-01678-5

2025

Anna Åstrand (2025) Pharmacology and Toxicity of New Psychoactive Substances: In vitro metabolism and receptor activation (Doctoral thesis, comprehensive summary) https://dx.doi.org/10.3384/9789181182361

2023

Matilda Backberg, Svante Vikingsson, Joakim Strandberg, Sara Wall, Anna Åstrand, Hanna Karlsson, Mattias Persson, Robert Kronstrand, Henrik Green (2023) Using in vitro receptor activity studies of synthetic cannabinoids to support the risk assessment of new psychoactive substances-A Swedish strategy to protect public health from harm Forensic Science International, Vol. 348, Article 111691 (Article in journal) https://dx.doi.org/10.1016/j.forsciint.2023.111691

2021

Robert Kronstrand, Anna Åstrand, Shimpei Watanabe, Henrik Green, Svante Vikingsson (2021) Circumstances, Postmortem Findings, Blood Concentrations and Metabolism in a Series of Methoxyacetylfentanyl-Related Deaths Journal of Analytical Toxicology, Vol. 45, p. 760-771 (Article in journal) https://dx.doi.org/10.1093/jat/bkab053

Anna Åstrand, Svante Vikingsson, Ingrid Jakobsen, Niclas Björn, Robert Kronstrand, Henrik Gréen (2021) Activation of the μ-opioid receptor by alicyclic fentanyls: Changes from high potency full agonists to low potency partial agonists with increasing alicyclic substructure Drug Testing and Analysis, Vol. 13, p. 169-174 (Article in journal) https://dx.doi.org/10.1002/dta.2906